Skip to main content

Peer Review reports

From: Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis

Original Submission
26 Jun 2020 Submitted Original manuscript
6 Jul 2020 Author responded Author comments - Shuyan Gu
Resubmission - Version 2
6 Jul 2020 Submitted Manuscript version 2
13 Sep 2020 Author responded Author comments - Shuyan Gu
12 Aug 2020 Reviewed Reviewer Report
18 Aug 2020 Reviewed Reviewer Report
Resubmission - Version 3
13 Sep 2020 Submitted Manuscript version 3
27 Oct 2020 Author responded Author comments - Shuyan Gu
14 Oct 2020 Reviewed Reviewer Report
16 Sep 2020 Reviewed Reviewer Report
Resubmission - Version 4
27 Oct 2020 Submitted Manuscript version 4
28 Oct 2020 Reviewed Reviewer Report
28 Oct 2020 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
2 Nov 2020 Editorially accepted
3 Dec 2020 Article published 10.1186/s12916-020-01837-x

You can find further information about peer review here.

Back to article page